Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
59 hedge funds and large institutions have $10.9M invested in Vaxxinity, Inc. Class A Common Stock in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
13% more funds holding
Funds holding: 52 → 59 (+7)
34% less capital invested
Capital invested by funds: $16.4M → $10.9M (-$5.48M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$410K |
| 2 |
BlackRock
New York
|
+$181K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$149K |
| 4 |
IC
IEQ Capital
Foster City,
California
|
+$80.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$76.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Scoggin Management
New York
|
-$206K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$136K |
| 3 |
State Street
Boston,
Massachusetts
|
-$32.1K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$16.7K |
| 5 |
SG Americas Securities
New York
|
-$14K |
VAXX Hedge Fund Activity: Q4 2023 in Review
59 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q4 2023, worth a combined $10.9M — down 34% from $16.4M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new VAXX positions and 4 closed out — a net gain of 8 holders — while 17 added to existing stakes and 9 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $410K. The largest seller was Scoggin Management, exiting entirely with an estimated $206K sold.
- 59 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q4 2023, up from 52 in Q3 2023.
- Funds reported $10.9M of Vaxxinity, Inc. Class A Common Stock stock for Q4 2023, down 34% quarter-over-quarter.
- 12 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q4 2023 and 4 closed out, a net change of +8 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q4 2023 was Morgan Stanley, an estimated $410K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q4 2023 was Scoggin Management, an estimated $206K sold.
Based on aggregated 13F filings for Q4 2023.